Today's Daily Dose brings you news about AbbVie's ulcerative colitis trial results; Chembio's preliminary Q3 revenue and stock offering; HealthStream's Q3 results and CFO resignation; Intec Pharma's progress in ACCORDANCE study, and acquisition of Therapix Biosciences by SD Pharma.
from RTT - Biotech https://ift.tt/2CyV0NF
via IFTTT
No comments:
Post a Comment